We pursue and are actively engaged in challenging research projects that enable us to make significant advances in science and engineering to benefit industry and society. Our track record in driving major interdisciplinary programmes in biotechnology has attracted more than £90M in external funding since MIB’s inception in 2006 and our portfolio continues to grow substantially primarily through a ‘tightening’ of our focus in areas of core strength (industrial biotechnology; synthetic biology; catalysis science; systems based research; biomedical biotechnology; fuels and energy research), and supported by strategic recruitment to new leadership positions in the Institute. Our research strengths are showcased in the ensuing pages defining our research Grand Challenges and showcasing a selected portfolio of projects that illustrate the diversity, quality and dynamism of our research teams. Our reputation as an international leader in the biotechnology field is evidenced with over 1400 publications, since 2009, in major journals and the impact of the Institute’s research is evident from a sustained commitment to the successful translation of basic science into commercial success.
As a leading industry-interfaced biotechnology institute we are proud to engage in technology transfers and have a number of strategic partnerships with companies from the chemical, biotechnology and biopharmaceutical sectors to translate research council funding into products and services for the betterment of all people and the environment across the globe.